UAB Doctor Developing Blood Test to Predict Depression
Beth Seibels of Birmingham is 62 years old and has suffered from anxiety and depression for more than 30 years. Two years ago, things got worse. For the first time, she was feeling suicidal.
“I was dying inside,” Seibels says. “You don’t see the other side. You believe that it’s going to be this way forever, and it causes such a hopelessness that you will never get your life back again.”
Seibels had seen countless counselors and psychiatrists and tried numerous different medications. Desperate, she even tried transcranial magnetic brain stimulation. Nothing was helping.
It wasn’t until Beth met psychiatrist Dr. Richard Shelton that her condition significantly improved.
Methods of screening for depression vary widely and most lab tests aren’t helpful. Patient interviews remain the most widely used tool a doctor has at his or her disposal. Many people go undiagnosed. But what if you could find out if you were at risk of becoming depressed or suicidal? Researchers at the University of Alabama at Birmingham are working to do just that.
As the mother of three grown children and nine grandchildren, Seibels worries that they could become victim to this devastating illness.
According to Shelton, who heads the newly formed Mood Disorders Research Center at the University of Alabama at Birmingham, that’s a common concern among patients. It’s something he and his counterpart, neurobiologist Yogesh Dwivedi, are trying to address. Using predictive analytics, they are working to develop a blood test that can detect risk with the ultimate goal of identifying people before they become depressed or even suicidal.
While common for other types of medical conditions, this has rarely, if ever, been done for a mental health malady. Shelton says it’s achievable and that early detection can save lives.
UAB
Dr. Richard Shelton.
“Once people are sick, it’s often hard to get them well again. And that’s true in cancer. That’s true in depression. That’s true for suicide,” says Shelton.
A blood test for depression already exists, but it can identify someone who’s already depressed. Similar to other medical conditions that use predictive analytics, Shelton’s plan is to refine and perfect the test.
“The work we are doing in the lab here – a blood test that we hope will ultimately help us to develop a way to detect who’s going to become depressed, and people who are going to become depressed who are likely to be suicidal in the future — it’s a big project,” says Shelton. “It involves a lot of complicated chemical analysis, but that’s really the long-term goal.”
The challenge he faces in the lab are thousands of tiny RNA sequences known as MicroRNAs – crucial players in gene expression and protein production. MicroRNAs can actually keep genes from expressing themselves, determining whether a particular protein will be produced. There are literally thousands of these MicroRNAs, and they are extremely sensitive to environmental effects. Shelton wants to understand how such factors, child abuse, chronic stress, death of a loved one, long-term changes in MicroRNAs.
Specifically, he wants to identify the smallest number of MicroRNAs that could be used to create a profile detectable in blood that can be extracted during a routine medical visit. This would ultimately allow clinicians to intervene before a patient becomes ill.
Longitudinal studies are currently underway. Shelton estimates developing the test could take as long as 30 years at his current funding level.
Birmingham is 3rd worst in the Southeast for ozone pollution, new report says
The American Lung Association's "State of the Air" report shows some metro areas in the Gulf States continue to have poor air quality.
Why haven’t Kansas and Alabama — among other holdouts — expanded access to Medicaid?
Only 10 states have not joined the federal program that expands Medicaid to people who are still in the "coverage gap" for health care
Once praised, settlement to help sickened BP oil spill workers leaves most with nearly nothing
Thousands of ordinary people who helped clean up after the 2010 BP oil spill in the Gulf of Mexico say they got sick. A court settlement was supposed to help compensate them, but it hasn’t turned out as expected.
Q&A: How harm reduction can help mitigate the opioid crisis
Maia Szalavitz discusses harm reduction's effectiveness against drug addiction, how punitive policies can hurt people who need pain medication and more.
The Gulf States Newsroom is hiring a Community Engagement Producer
The Gulf States Newsroom is seeking a curious, creative and collaborative professional to work with our regional team to build up engaged journalism efforts.
Gambling bills face uncertain future in the Alabama legislature
This year looked to be different for lottery and gambling legislation, which has fallen short for years in the Alabama legislature. But this week, with only a handful of meeting days left, competing House and Senate proposals were sent to a conference committee to work out differences.
